Evidence map›Paper›PMID 37098531›Full record

ArticleOrphanet journal of rare diseases2023

Transition for adolescents with a rare disease: results of a nationwide German project.

Corinna Grasemann, Jakob Höppner, Peter Burgard, Michael M Schündeln, Nora Matar, Gabriele Müller, Heiko Krude, Reinhard Berner, Min Ae Lee-Kirsch, Fabian Hauck and 19 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Orphanet journal of rare diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Guideline
  2. [Transition and transfer from pediatrics to adult medicine].Wiener medizinische Wochenschrift (1946) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The importance of genetic counselling for turner syndrome transition.European child & adolescent psychiatry · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. [Rare diseases in a medical genetics service of population with social security].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Article
  17. Article
  18. "Living with"Frontiers in neurology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 10 institutions in 1 country.

Corinna GrasemannDivision of Rare Diseases, Department of Paediatrics, St. Josef-Hospital Bochum, Ruhr-University Bochum, Alexandrinenstraße 5, 44791, Bochum, Germany. corinna.grasemann@rub.de.ORCID 0000-0003-1793-4603
Jakob HöppnerDivision of Rare Diseases, Department of Paediatrics, St. Josef-Hospital Bochum, Ruhr-University Bochum, Alexandrinenstraße 5, 44791, Bochum, Germany.ORCID 0000-0001-9908-2066
Peter BurgardCentre for Child and Adolescent Medicine and and Centre for Rare Diseases, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0003-0665-8025
Michael M SchündelnDepartment of Paediatrics III, University Hospital Essen, University Duisburg-Essen, Essen, Germany.ORCID 0000-0001-7495-9060
Nora MatarDivision of Rare Diseases, Department of Paediatrics, St. Josef-Hospital Bochum, Ruhr-University Bochum, Alexandrinenstraße 5, 44791, Bochum, Germany.
Gabriele MüllerCentre for Evidence-Based Healthcare, Carl Gustav Carus Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.ORCID 0000-0002-1591-0539
Heiko KrudeInstitute for Experimental Paediatric Endocrinology and Centre for Rare Diseases, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Reinhard BernerChildren's Department and University Centre for Rare Diseases (USE), University Hospital Dresden, Dresden, Germany.
Min Ae Lee-KirschChildren's Department and University Centre for Rare Diseases (USE), University Hospital Dresden, Dresden, Germany.
Fabian HauckDr von Hauner Children's Hospital, University Hospital and Munich Centre for Rare Diseases (M-ZSELMU), Ludwig-Maximilians-University Munich, Munich, Germany.ORCID 0000-0001-9644-2003
Kerstin WainwrightInstitute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Sylvana BaumgartenInstitute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Janet AtingaDivision of Rare Diseases, Department of Paediatrics, St. Josef-Hospital Bochum, Ruhr-University Bochum, Alexandrinenstraße 5, 44791, Bochum, Germany.
Jens J BauerDivision of Rare Diseases, Department of Paediatrics, St. Josef-Hospital Bochum, Ruhr-University Bochum, Alexandrinenstraße 5, 44791, Bochum, Germany.
Eva MankaDepartment of Paediatrics II and Essener Centre for Rare Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Julia KörholzChildren's Department and University Centre for Rare Diseases (USE), University Hospital Dresden, Dresden, Germany.
Cordula KiewertDepartment of Paediatrics II and Essener Centre for Rare Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
André HeinenChildren's Department and University Centre for Rare Diseases (USE), University Hospital Dresden, Dresden, Germany.
Tanita KretschmerChildren's Department and University Centre for Rare Diseases (USE), University Hospital Dresden, Dresden, Germany.
Tobias KurthInstitute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-7169-2620
Janna MittnachtCentre for Child and Adolescent Medicine and and Centre for Rare Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Christoph SchrammMartin Zeitz Centre for Rare Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Christoph KleinDr von Hauner Children's Hospital, University Hospital and Munich Centre for Rare Diseases (M-ZSELMU), Ludwig-Maximilians-University Munich, Munich, Germany.
Holm GraessnerInstitute for Medical Genetics and Applied Genomics, University of Tuebingen, Tübingen, Germany.
Olaf HiortDepartments of Paediatrics, University Medical Centre Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Ania C MuntauUniversity Children's Hospital, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
Annette GrütersInstitute for Experimental Paediatric Endocrinology and Centre for Rare Diseases, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Georg F HoffmannCentre for Child and Adolescent Medicine and and Centre for Rare Diseases, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0002-6593-896X
Daniela ChoukairCentre for Child and Adolescent Medicine and and Centre for Rare Diseases, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0002-1631-3883
University Hospital Carl Gustav Carus · DECharité - Universitätsmedizin Berlin · DEHeidelberg University · DEWitten/Herdecke University · DELudwig-Maximilians-Universität München · DEUniversität Hamburg · DESt. Josef-Hospital · DEUniversity Hospitals of the Ruhr-University of Bochum · DEUniversity of Duisburg-Essen · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe transition process from paediatric/adolescent to adult medical care settings is of utmost importance for the future health of adolescents with chronic diseases and poses even more difficulties in the context of rare diseases (RDs). Paediatric care teams are challenged to deliver adolescent-appropriate information and structures. Here we present a structured transition pathway which is patient-focused and adoptable for different RDs.

methodsThe transition pathway for adolescents 16 years and older was developed and implemented as part of a multi-centre study in 10 university hospitals in Germany. Key elements of the pathway included: assessment of patients' disease-related knowledge and needs, training/educational and counselling sessions, a structured epicrisis and a transfer appointment jointly with the paediatric and adult specialist. Specific care coordinators from the participating university hospitals were in charge of organization and coordination of the transition process.

resultsOf a total of 292 patients, 286 completed the pathway. Deficits in disease-specific knowledge were present in more than 90% of participants. A need for genetic or socio-legal counselling was indicated by > 60%. A mean of 2.1 training sessions per patient were provided over a period of almost 1 year, followed by the transfer to adult care in 267 cases. Twelve patients remained in paediatric care as no adult health care specialist could be identified. Targeted training and counselling resulted in improved disease-specific knowledge and contributed to empowering of patients.

conclusionThe described transition pathway succeeds to improve health literacy in adolescents with RDs and can be implemented by paediatric care teams in any RD specialty. Patient empowerment was mainly achieved by individualized training and counselling.

Indexed as

Patient ParticipationRare DiseasesAdolescentChildChronic DiseaseGermanyHumansAdolescent healthEmpowermentHealth literacyPathwayRare diseaseTransition

Identifiers

PMID37098531
PMCPMC10131406
OpenAlexW4366983825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.